Torres soon realized the potential of their joint expertise to drive a step change in ADC efficacy and safety, so he approached them to co-found CrossBridge Bio in 2023. “We can now put the ...
Taiho Pharma to buy next-generation ADC drug discovery company ,Araris Biotech: Japan Tuesday, March 18, 2025, 16:00 Hrs [IST] Taiho Pharmaceutical Co., Ltd., an R&D-driven specia ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果